Martin Gygax

Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium.

Patrick Choay SA operates as a holding company. The company is headquartered in Castelfranco Paris, France.

Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France.

DMS Biotechnology Sprl develops biotechnology products. The private company is based in Mont-Saint-Guibert, Belgium.

Telix Pharmaceuticals SAS engages in the pharmaceutical industry. It provides research in biotechnology. The company was founded on July 25, 2008 and is headquartered in Nantes, France.

OGD2 Pharma SAS develops and commercializes anti-GD2 cancer immunotherapies that target O-acetylated-GD2. The firm continues exploring the potential of therapies targeting the OAcGD2 antigen in various cancers. The company is headquartered in Nantes, France.

Medevice Accelerator SAS (Medevice Accelerator) is an independent venture capital firm founded in 2011 by Cécile Réal. The firm is located in Chavanod (Alpes), France.